Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

912 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adolescents and young adults with a "rare" cancer: getting past semantics to optimal care for patients with germ cell tumors.
Stoneham SJ, Hale JP, Rodriguez-Galindo C, Dang H, Olson T, Murray M, Amatruda JF, Thornton C, Arul GS, Billmire D, Krailo M, Stark D, Covens A, Hurteau J, Stenning S, Nicholson JC, Gershenson D, Frazier AL. Stoneham SJ, et al. Among authors: olson t. Oncologist. 2014 Jul;19(7):689-92. doi: 10.1634/theoncologist.2014-0009. Epub 2014 Jun 4. Oncologist. 2014. PMID: 24899644 Free PMC article.
Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
Cushing B, Giller R, Cullen JW, Marina NM, Lauer SJ, Olson TA, Rogers PC, Colombani P, Rescorla F, Billmire DF, Vinocur CD, Hawkins EP, Davis MM, Perlman EJ, London WB, Castleberry RP; Pediatric Oncology Group 9049; Children's Cancer Group 8882. Cushing B, et al. J Clin Oncol. 2004 Jul 1;22(13):2691-700. doi: 10.1200/JCO.2004.08.015. J Clin Oncol. 2004. PMID: 15226336 Clinical Trial.
Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891.
Rogers PC, Olson TA, Cullen JW, Billmire DF, Marina N, Rescorla F, Davis MM, London WB, Lauer SJ, Giller RH, Cushing B; Pediatric Oncology Group 9048; Children's Cancer Group 8891. Rogers PC, et al. J Clin Oncol. 2004 Sep 1;22(17):3563-9. doi: 10.1200/JCO.2004.01.006. J Clin Oncol. 2004. PMID: 15337806 Clinical Trial.
Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study.
Marina N, Chang KW, Malogolowkin M, London WB, Frazier AL, Womer RB, Rescorla F, Billmire DF, Davis MM, Perlman EJ, Giller R, Lauer SJ, Olson TA; Children's Oncology Group. Marina N, et al. Cancer. 2005 Aug 15;104(4):841-7. doi: 10.1002/cncr.21218. Cancer. 2005. PMID: 15999362 Free article.
Application of the adult international germ cell classification system to pediatric malignant non-seminomatous germ cell tumors: a report from the Children's Oncology Group.
Frazier AL, Rumcheva P, Olson T, Giller R, Cushing B, Cullen J, Marina N, London WB; Children's Oncology Group. Frazier AL, et al. Among authors: olson t. Pediatr Blood Cancer. 2008 Apr;50(4):746-51. doi: 10.1002/pbc.21304. Pediatr Blood Cancer. 2008. PMID: 18085675 Free PMC article.
Pilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors: a report of the children's oncology group (COG).
Malogolowkin MH, Krailo M, Marina N, Olson T, Frazier AL. Malogolowkin MH, et al. Among authors: olson t. Pediatr Blood Cancer. 2013 Oct;60(10):1602-5. doi: 10.1002/pbc.24601. Epub 2013 May 23. Pediatr Blood Cancer. 2013. PMID: 23703725 Free PMC article. Clinical Trial.
Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group.
Billmire DF, Cullen JW, Rescorla FJ, Davis M, Schlatter MG, Olson TA, Malogolowkin MH, Pashankar F, Villaluna D, Krailo M, Egler RA, Rodriguez-Galindo C, Frazier AL. Billmire DF, et al. J Clin Oncol. 2014 Feb 10;32(5):465-70. doi: 10.1200/JCO.2013.51.1006. Epub 2014 Jan 6. J Clin Oncol. 2014. PMID: 24395845 Free PMC article.
Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States.
Frazier AL, Hale JP, Rodriguez-Galindo C, Dang H, Olson T, Murray MJ, Amatruda JF, Thornton C, Arul GS, Billmire D, Shaikh F, Pashankar F, Stoneham S, Krailo M, Nicholson JC. Frazier AL, et al. Among authors: olson t. J Clin Oncol. 2015 Jan 10;33(2):195-201. doi: 10.1200/JCO.2014.58.3369. Epub 2014 Dec 1. J Clin Oncol. 2015. PMID: 25452439 Free PMC article.
Impact of central surgical review in a study of malignant germ cell tumors.
Billmire DF, Rescorla FJ, Ross JH, Schlatter MG, Dicken BJ, Krailo MD, Rodriguez-Galindo C, Olson TA, Cullen JW, Frazier AL. Billmire DF, et al. J Pediatr Surg. 2015 Sep;50(9):1502-5. doi: 10.1016/j.jpedsurg.2014.12.008. Epub 2014 Dec 17. J Pediatr Surg. 2015. PMID: 25783295 Free PMC article.
912 results